One of potential therapeutic approaches in cancer treatment is to reactivate apoptosis of transformed cells using member of TNF (tumor necrosis factor)-family, of which the TNF-related apoptosis-inducing ligand (TRAIL) gained much attention due to its therapeutic potential as a tumor-specific apoptosis inducer with no obvious cytotoxicity on normal cells (2). This evidence concerns the gene TNFSF10 and cancer.